LivaNova PLC LivaNova PLC

LivaNova PLC

LIVN

株式のランク #3706
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
株価
$81.22
時価総額
$4.46B
変化(1日)
3.54%
変化(1年)
48.07%
国
GB
取引 LivaNova PLC (LIVN)

カテゴリー

Healthcare
LivaNova PLC(LIVN)の株価履歴
終値の最高値: $77.04 (2026-10-01)

終値の最安値: $65.54 (2015-10-01)
LivaNova PLC の株価履歴(2015 ~ 2026)
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 10.24%
2025 28.07%
2024 0.72%
2023 -10.64%
2022 -34.07%
2021 32.23%
2020 -19.53%
2019 -16.15%
2018 13.93%
2017 79.34%
2016 -22.00%
2015 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
$102.65 -19.77%
US
$96.45 0.57%
IE
$307.12 -20.92%
US
$46.02 -55.69%
US
$47.05 -17.88%
DE